Application of antisense ribonucleic acid complementary to O6- methylguanine-deoxyribonucleic acid methyltransferase messenger ribonucleic acid for therapy of malignant gliomas

Neurosurgery

Volumn 41, Issue 2, 1997, Pages 434-441

  Nagane, Motoo ^a   Asai, Akio ^c   Shibui, Soichiro ^a   Nomura, Kazuhiro ^a   Kuchino, Yoshiyuki ^b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

ACNU resistant glioma cell line; Antisense MGMT RNA; Glioma therapy; O6 Methylguanine DNA methyltransferase MGMT); Rat glioma cell line C6

Indexed keywords

CHLOROETHYLNITROSOUREA; COMPLEMENTARY RNA; DNA (CYTOSINE 5) METHYLTRANSFERASE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; COLONY FORMING UNIT; GLIOBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; RNA TRANSCRIPTION; SURVIVAL RATE;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTISENSE ELEMENTS (GENETICS); DRUG RESISTANCE, NEOPLASM; GLIOMA; METHYLTRANSFERASES; NIMUSTINE; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PROTEIN BIOSYNTHESIS; RATS; RNA, COMPLEMENTARY; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030833675     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199708000-00021     Document Type: Article

References (38)

1. Becker D, Meier CB, Herlyn M: Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO J 8:3685-3691, 1989.
2. 6-benzylguanine in vitro. Carcinogenesis 14:1057-1060, 1993.
3. 6-methylguanine-DNA methyltransferase in human normal and tumor tissue from brain, lung, and ovary. Cancer Res 51:4131-4134, 1991.
4. Citti L, Boldrini L, Rainaldi G: The genotoxicity of the chloroethylating agent mitozolomide is enhanced in CHO mex+ cells by the administration of antimessenger oligonucleotide targeted against methylguanine-DNA methyltransferase gene (MGMT). Anticancer Res 14:2667-2671, 1994.
5. Colotta F, Polentarutti N, Sironi M, Mantovani A: Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid celi lines. J Biol Chem 267:18278-18283, 1992.
6. Committee of the Brain Tumor Registry of Japan: The seventh report from the Brain Tumor Registry of Japan. Neurol Med Chir (Tokyo) 32:385-547, 1992.
7. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256:1550-1552, 1992.
8. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc Natl Acad Sci U S A 87:5368-5372, 1990.
9. Felgner PL, Gadek TR, Holm TR, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielson M: Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 84:7413-7417, 1987.
10. 6-methylguanine-DNA methyltransferase gene MGMT in MER+ and MER- human tumor cells. Cancer Res 50:7908-7911, 1990.
11. Geller AI, Keyomarsi K, Bryan J, Pardee AB: An efficient deletion mutant packaging system for defective herpes simplex virus vectors: Potential applications to human gene therapy and neuronal physiology. Proc Natl Acad Sci U S A 87:8950-8954, 1990.
12. Gibson N, Hartley J, Barnes D, Erickson L: Combined effect of streptozotocin and mitozolomide against four human cell lines of the MER+ phenotype. Cancer Res 46:4995-4998, 1986.
13. Gossen M, Bujard H: Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89:5547-5551, 1992.
14. Gossen M, Bonin AL, Bujard H: Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. Trends Biochem Sci 18:471-475, 1993.
15. Greene GM, Hitchon PW, Schelper RL, Yuh W, Dyste GN: Diagnostic yield in CT-guided stereotactic biopsy of gliomas. J Neurosurg 71:494-197, 1989.
16. Hara A, Niikawa S, Zhang W, Sakai N, Yamada H, Yoshimi N, Mori H: Identification of placental form of glutathione S-transferase in ACNU-resistant murine glioma cell lines. J Neurooncol 17:205-213, 1993.
17. Hjalt T, Wagner EG: The effect of loop size in antisense and target RNAs on the efficiency of antisense RNA control. Nucleic Acids Res 20:6723-6732, 1992.
18. Inouye M: Antisense RNA: Its functions and applications in gene regulation - A review. Gene 72:25-34, 1988.
19. Izant JC, Wcintraub H: Constitutive and conditional suppression of exogenous and endogenous genes by anti-sense RNA. Science 229:345-352, 1985.
20. Kohn K: Interstrand cross-linking of DNA by 1,3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosoureas. Cancer Res 37:1450-1454, 1977.
21. Levin V, Wilson C: Nitrosourea chemotherapy for primary malignant gliomas. Cancer Treat Rep 60:719-724, 1976.
22. Maran A, Maitra RK, Kumar A, Dong B, Xiao W, Silverman RH: Blockage of NF-κB signaling by selective ablation of an mRNA target by 2-5A antisense chimeras. Science 265:789-792, 1994.
23. 6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity. Cancer Res 54:4371-4375, 1994.
24. Miyao Y, Shimizu K, Moriuchi S, Yamada M, Nakahira K, Nakajima K, Nakao J, Kuriyama S, Tsujii T, Mikoshiba K: Selective expression of foreign genes in glioma cells: Use of the mouse myelin basic protein gene promoter to direct toxic gene expression. J Neurosci Res 36:472-479, 1993.
25. Mizuno M, Yoshida J, Sugita K: Growth inhibition of glioma cells transfected with the human β-interferon gene by liposomes coupled with a monoclonal antibody. Cancer Res 50:7826-7829, 1990.
26. 6-methylguanine-DNA methyltransferase and chloroethylnitrosourea resistance of human brain tumors. Jpn J Clin Oncol 22:143-149, 1992.
27. Neckers L, Whitesell L: Antisense technology: Biological utility and practical considerations. Am J Physiol 265:L1-L12, 1993.
28. 6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 50:6119-6129, 1990.
29. 6-methylguanine-DNA methyltransferase expression. Cancer Res 53:1731-1734, 1993.
30. 6-methylguanine-DNA methyltransferase. Nucleic Acids Research 11:7743-7758, 1983.
31. 6-methylguanine-DNA methyltransferase. Nucleic Acids Res 19:5597-5601, 1991.
32. Scanlon KJ, Ohta Y, Ishida H, Kijima H, Ohkawa T, Kaminski A, Tsai J, Horng G, Kashani SM: Oligonucleotide-mediated modulation of mammalian gene expression. FASEB J 9:1288-1296, 1995.
33. Takakura K, Abe H, Tanaka R, Kitamura K, Miwa T, Takeuchi K, Yamamoto S, Kageyama N, Handa H, Mogami H, Nishimoto A, Uozumi T, Matsutani M, Nomura K: Effects of ACNU and radiotherapy on malignant glioma. J Neurosurg 64:53-57, 1986.
34. Takamiya Y, Short MP, Moolten FL, Fleet C, Mineta T, Breakefield XO, Martuza RL: An experimental model of retrovirus gene therapy for malignant brain tumors. J Neurosurg 79:104-110, 1993.
35. 6-ethylguanine in DNA protects rat 208F cells from tumorigenic conversion by N-ethyl-N-nitrosourea Proc Natl Acad Sci USA 87:9883-9887, 1990.
36. Trojan J, Blossey BK, Johnson TR, Rudin SD, Tykocinski M, Ilan J, Ilan J: Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. Proc Natl Acad Sci U S A 89:4874-4878, 1992.
37. Wang Y, O'Malley BW Jr, Tsai SY, O'Malley BW: A regulatory system for use in gene transfer. Proc Natl Acad Sci USA 91:8180-8184, 1994.
38. Yarranton GT: Inducible vectors for expression in mammalian cells. Curr Opin Biotechnol 3:506-511, 1992.